Clinical Trials Browser

Phase 3 × NIH × Histamine × Clear all

NCT00039234 2013-12-18

Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Stage IV Melanoma Metastatic to the Liver

Phase 3 Unknown

Melanoma, Neoplasm Metastasis

NCT00003991 2013-11-06

Interleukin-2 Plus Histamine Dihydrochloride in Treating Patients With Acute Myeloid Leukemia

Phase 3 Completed

Other hematologic neoplasm

Leukemia